Susan Hasty, Publisher
Table of Contents . . . July 12th, 1999
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Hepatitis Weekly | Other Publications
Transmission - Mother-to-Infant HGV Risk is Great
Therapy (HBV) - Defective Genomes May Lessen IFN Efficacy in HBV Patients
Immunization - Hepatitis Vaccine Guidelines Aren't Being Followed
Immunization (HBV) - Annual Vaccination Schedule is Efficacious
Pathogenesis (HCV) - TNF-(alpha) TNFRs is Involved in Fibrosis
Therapy - UDCA May Be Useful Against Certain HCVs
Therapy (HCV) - Low-Titre Antibodies in IFN Recipients Point to Complications
Transmission (HCV) - Spouse-to-Spouse Hepatitis C is Studied
Virology (HBV) - T-Cell Response May Control Viremia During Vaccine Therapy
Sjogren's Syndrome - HCV is Infrequent Cause of Sjogren's Syndrome
GBV-C/HGV - French Blood Donors Exposed to Novel Virus
Screening (HCV) - Individual Genomic Screening Method Shows High Performance
Hepatitis C Virus - House Subcommittee Urged To Fortify Response To U.S. Veterans Needs
HBV Vaccines - "Response to HBV Vaccine in Cirrhotic Patients on Liver Transplant Waiting List."
Disease Associations - "Role of Iron in HCV Related Chronic Hepatitis."
Disease Associations - "Serum Ferritin Behavior in Patients with Chronic Hepatitis C Treated with Interferon."
Long-Term Antiviral Therapy (HCV) - "Long-Term Effect of Interferon-(alpha) for HCV Infection in Post-Liver Transplantation: Actual 7 to 9 Years Follow-Up. In
Disease Associations (HCV) - "Association Between Hepatitis C Virus and non-Hodgkin's Lymphoma, and Effects of Viral Infection on Histologic Subtype and Clinical Course."
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.